Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis

NCT04181762 ·Status: TERMINATED ·Phase: PHASE3

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

NCT05268289 ·Status: RECRUITING ·Phase: PHASE2

Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis

NCT00125307 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations

NCT01410747 ·Status: COMPLETED

Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis

NCT02630628 ·Status: COMPLETED ·Phase: PHASE3

Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis

NCT01580865 ·Status: COMPLETED ·Phase: NA

Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis

NCT01203709 ·Status: COMPLETED ·Phase: PHASE4

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

NCT05126277 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Etanercept for the Treatment of Lupus Nephritis

NCT00447265 ·Status: TERMINATED ·Phase: PHASE2

Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis

NCT00371319 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus

NCT05916781 ·Status: RECRUITING ·Phase: PHASE4

A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis

NCT04924296 ·Status: UNKNOWN ·Phase: PHASE2

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

NCT05138133 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis

NCT01206569 ·Status: COMPLETED ·Phase: PHASE4

A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis

NCT00404794 ·Status: COMPLETED ·Phase: PHASE3

Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone

NCT00268567 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis

NCT05207358 ·Status: RECRUITING ·Phase: PHASE4

A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

NCT06015737 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

NCT00035308 ·Status: COMPLETED ·Phase: PHASE3

Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE)

NCT01381536 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

NCT01316133 ·Status: TERMINATED ·Phase: PHASE4

Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis

NCT01207297 ·Status: COMPLETED ·Phase: PHASE1

Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis

NCT05863936 ·Status: UNKNOWN ·Phase: PHASE3

Atacicept in Subjects With Active Lupus Nephritis (COMPASS)

NCT05609812 ·Status: WITHDRAWN ·Phase: PHASE3

Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis

NCT01773616 ·Status: TERMINATED ·Phase: PHASE3